UnitedHealth Group Incorporated $UNH Stock: Oppenheimer & Co. Inc. Raises Position

Oppenheimer & Co. Inc. lifted its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 23.1% during the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 36,320 shares of the healthcare conglomerate’s stock after acquiring an additional 6,817 shares during the period. Oppenheimer & Co. Inc.’s holdings in UnitedHealth Group were worth $13,332,000 as of its most recent SEC filing.

Other institutional investors have also recently added to or reduced their stakes in the company. BlackRock Inc. boosted its stake in shares of UnitedHealth Group by 4.6% during the 2nd quarter. BlackRock Inc. now owns 76,863,061 shares of the healthcare conglomerate’s stock worth $31,946,594,000 after purchasing an additional 3,395,530 shares during the last quarter. State Street Corp grew its holdings in shares of UnitedHealth Group by 0.7% during the second quarter. State Street Corp now owns 45,633,267 shares of the healthcare conglomerate’s stock worth $18,966,555,000 after buying an additional 301,081 shares in the last quarter. Bank of New York Mellon Corp raised its position in shares of UnitedHealth Group by 6.1% in the second quarter. Bank of New York Mellon Corp now owns 10,704,994 shares of the healthcare conglomerate’s stock valued at $4,449,317,000 after buying an additional 616,723 shares during the last quarter. Wellington Management Group LLP lifted its stake in shares of UnitedHealth Group by 5.8% during the second quarter. Wellington Management Group LLP now owns 10,675,175 shares of the healthcare conglomerate’s stock valued at $4,436,923,000 after buying an additional 583,536 shares during the period. Finally, Corient Private Wealth LP lifted its stake in shares of UnitedHealth Group by 1,443.7% during the second quarter. Corient Private Wealth LP now owns 8,447,224 shares of the healthcare conglomerate’s stock valued at $3,510,920,000 after buying an additional 7,900,011 shares during the period. Institutional investors and hedge funds own 87.86% of the company’s stock.

Analyst Ratings Changes

Several analysts have commented on UNH shares. Argus lifted their target price on shares of UnitedHealth Group from $400.00 to $470.00 and gave the stock a “buy” rating in a research note on Monday, July 20th. HSBC increased their price target on UnitedHealth Group from $300.00 to $380.00 and gave the stock a “hold” rating in a research note on Monday, July 6th. UBS Group restated an “outperform” rating on shares of UnitedHealth Group in a report on Tuesday, October 13th. Leerink Partners upped their target price on UnitedHealth Group from $462.00 to $472.00 and gave the company an “outperform” rating in a research note on Friday, July 17th. Finally, Weiss Ratings upgraded UnitedHealth Group from a “hold (c-)” rating to a “hold (c)” rating in a research report on Thursday, October 8th. Twenty investment analysts have rated the stock with a Buy rating and eight have given a Hold rating to the company’s stock. According to MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $463.93.

UnitedHealth Group Stock Performance

UnitedHealth Group stock opened at $410.72 on Wednesday. UnitedHealth Group Incorporated has a 1 year low of $255.96 and a 1 year high of $461.62. The firm has a 50 day moving average price of $389.07 and a 200 day moving average price of $361.44.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings results on Tuesday, October 13th. The healthcare conglomerate reported $4.69 earnings per share for the quarter, topping analysts’ consensus estimates of $4.14 by $0.55. The company had revenue of $112.70 billion for the quarter, compared to analysts’ expectations of $111.31 billion. The business’s revenue for the quarter was down .4% on a year-over-year basis. During the same period in the prior year, the business earned $2.59 EPS. UnitedHealth Group has set its FY 2026 guidance at 20.500- EPS. Equities research analysts expect that UnitedHealth Group Incorporated will post 20.62 earnings per share for the current fiscal year.

UnitedHealth Group Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Tuesday, September 22nd. Investors of record on Monday, September 14th were given a $2.32 dividend. This represents a $9.28 annualized dividend and a dividend yield of 2.3%. The ex-dividend date of this dividend was Monday, September 14th.

Insider Buying and Selling at UnitedHealth Group

In related news, CEO Patrick Conway sold 1,169 shares of UnitedHealth Group stock in a transaction on Friday, August 21st. The stock was sold at an average price of $390.00, for a total value of $455,910.00. Following the transaction, the chief executive officer owned 15,328 shares in the company, valued at approximately $5,977,920. This trade represents a 7.09% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Company insiders own 0.19% of the company’s stock.

UnitedHealth Group Profile

UnitedHealth Group Incorporated (NYSE: UNH) is a diversified health care company that provides health insurance coverage, health care services, pharmacy services and health technology. Its businesses serve individuals, employers, government programs, health care providers and other organizations, primarily in the United States.

The company operates through two principal businesses. UnitedHealthcare offers health benefit plans and related services for employers, individuals, families and government-sponsored programs, including Medicare and Medicaid.